• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高脂血症患者治疗前后高密度脂蛋白胆固醇及总胆固醇与高密度脂蛋白胆固醇比值的数值。

Pre- and post-treatment values of HDL cholesterol and total: HDL cholesterol ratio in hyperlipoproteinaemic subjects.

作者信息

Sale J K, Johnstone J H

出版信息

Ann Clin Biochem. 1981 Mar;18 (Pt 2):71-5. doi: 10.1177/000456328101800203.

DOI:10.1177/000456328101800203
PMID:7259072
Abstract

High-density lipoprotein (HDL) cholesterol, total cholesterol, and triglyceride concentrations were measured in fasting blood samples from 74 controls and 185 patients with untreated primary hyperlipoproteinaemia. The mean HDL cholesterol levels and the total cholesterol:HDL cholesterol ratios were significantly different between male and female subjects. Only patients with Fredrickson type IV hyperlipoproteinaemia had HDL cholesterol concentrations significantly lower than controls, but all subjects with hyperlipoproteinaemia had total:HDL cholesterol ratios significantly higher than control values. Subsequent investigations were performed on 31 patients during treatment of the hyperlipoproteinaemia by diet alone or in combination with clofibrate. Responses were variable, but generally improvements in the concentrations of triglyceride and total cholesterol were accompanied by an unchanged or decreased total:HDL cholesterol ratio, although there was not necessarily an increase in the HDL cholesterol itself.

摘要

在74名对照者和185名未经治疗的原发性高脂蛋白血症患者的空腹血样中,检测了高密度脂蛋白(HDL)胆固醇、总胆固醇和甘油三酯浓度。男性和女性受试者的平均HDL胆固醇水平以及总胆固醇与HDL胆固醇的比值存在显著差异。只有弗雷德里克森IV型高脂蛋白血症患者的HDL胆固醇浓度显著低于对照者,但所有高脂蛋白血症患者的总胆固醇与HDL胆固醇比值均显著高于对照值。随后,对31名通过单纯饮食或联合氯贝丁酯治疗高脂蛋白血症的患者进行了后续研究。反应各不相同,但总体而言,甘油三酯和总胆固醇浓度的改善伴随着总胆固醇与HDL胆固醇比值不变或降低,尽管HDL胆固醇本身不一定会增加。

相似文献

1
Pre- and post-treatment values of HDL cholesterol and total: HDL cholesterol ratio in hyperlipoproteinaemic subjects.高脂血症患者治疗前后高密度脂蛋白胆固醇及总胆固醇与高密度脂蛋白胆固醇比值的数值。
Ann Clin Biochem. 1981 Mar;18 (Pt 2):71-5. doi: 10.1177/000456328101800203.
2
The concentration of high density lipoprotein in patients with type IV hyperlipoproteinemia and the effect of clofibrate.IV型高脂蛋白血症患者高密度脂蛋白的浓度及氯贝丁酯的作用。
Atherosclerosis. 1980 Aug;36(4):461-9. doi: 10.1016/0021-9150(80)90239-7.
3
[Effect of diet and drug therapy on the level of high density lipoprotein cholesterol in patients with primary hyperlipoproteinemia].[饮食与药物治疗对原发性高脂蛋白血症患者高密度脂蛋白胆固醇水平的影响]
Klin Med (Mosk). 1981 Sep;59(9):45-8.
4
[Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].[氯贝丁酯-烟酸肌醇酯联合用药对IIa型、IV型和V型原发性高脂蛋白血症患者血脂及脂蛋白的影响]
Arzneimittelforschung. 1983;33(5):776-9.
5
Dose-response study of the effect of ciprofibrate on serum lipoprotein concentrations in hyperlipoproteinaemia.环丙贝特对高脂蛋白血症患者血清脂蛋白浓度影响的剂量反应研究。
Atherosclerosis. 1982 Apr;42(2-3):229-43. doi: 10.1016/0021-9150(82)90153-8.
6
[Quantitative analysis of lipoproteins in hyperlipoproteinemias of type IIa, IIb and IV (author's transl)].IIa、IIb和IV型高脂蛋白血症中脂蛋白的定量分析(作者译)
Clin Chim Acta. 1979 Oct 15;98(1-2):19-26. doi: 10.1016/0009-8981(79)90160-8.
7
Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease.在动脉粥样硬化疾病患者中,联合降脂治疗可显著降低脂蛋白脂质水平。
Atherosclerosis. 1979 Aug;33(4):457-77. doi: 10.1016/0021-9150(79)90038-8.
8
[The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].[苯扎贝特对各型高脂蛋白血症的治疗效果]
Schweiz Med Wochenschr. 1980 Dec 6;110(49):1875-7.
9
Diet and high density lipoproteins.饮食与高密度脂蛋白
Lipids. 1981 Feb;16(2):93-7. doi: 10.1007/BF02535680.
10
[Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].[高脂蛋白血症、高密度脂蛋白胆固醇与动脉硬化指数]
Z Gesamte Inn Med. 1982 Dec 15;37(24):830-3.